Weight Loss
Peptides studied for their effects on appetite, fat metabolism, and sustained weight loss.
Weight loss is the most rapidly growing area of peptide therapeutics, driven by the GLP-1 revolution. FDA-approved peptides like semaglutide and tirzepatide have demonstrated 15-25% body weight reduction in clinical trials, fundamentally changing the obesity treatment landscape. Beyond GLP-1s, other peptides target fat metabolism through different mechanisms — from growth hormone fragment AOD-9604 to the mitochondrial peptide MOTS-c. The evidence varies dramatically between compounds, from robust Phase III trial data to purely preclinical research.
Peptides for Weight Loss
Related Research & Insights
The Most Popular Peptides of 2026
From oral GLP-1 pills and triple agonists to the FDA reclassification saga and a copper peptide going viral — what's driving 10 million monthly peptide searches.
Foundayo vs Oral Wegovy: The Battle of the GLP-1 Pills
Eli Lilly's small-molecule pill vs Novo Nordisk's peptide tablet. One is more convenient, the other more effective. Here's what the data shows — and why no head-to-head trial exists yet.
Will Peptides Work for Me? What Genetics, Sex, and Phenotype Tell Us
A landmark 2026 Nature study of 27,885 people found genetic variants that predict GLP-1 drug response. But genetics is just one piece — here's the full picture of why peptides work differently for different people.
Oral vs Injectable Peptides: What Foundayo's Approval Means for the Future
Eli Lilly's oral GLP-1 pill eliminates injections entirely. Here's how oral and injectable peptide delivery compare — and why the future of peptide therapy may be swallowed, not injected.